Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients.

Wilhelm KR, Yanamandra K, Gruden MA, Zamotin V, Malisauskas M, Casaite V, Darinskas A, Forsgren L, Morozova-Roche LA.

Eur J Neurol. 2007 Mar;14(3):327-34.

PMID:
17355556
2.

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Yanamandra K, Gruden MA, Casaite V, Meskys R, Forsgren L, Morozova-Roche LA.

PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.

3.

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression.

Gruden MA, Sewell RD, Yanamandra K, Davidova TV, Kucheryanu VG, Bocharov EV, Bocharova OA, Polyschuk VV, Sherstnev VV, Morozova-Roche LA.

J Neuroimmunol. 2011 Apr;233(1-2):221-7. doi: 10.1016/j.jneuroim.2010.12.001. Epub 2011 Jan 15. Erratum in: J Neuroimmunol. 2014 Mar 15;268(1-2):99. Bocharova, Olga R [corrected to Bocharova, Olga A].

PMID:
21239064
4.

Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.

Maetzler W, Apel A, Langkamp M, Deuschle C, Dilger SS, Stirnkorb JG, Schulte C, Schleicher E, Gasser T, Berg D.

PLoS One. 2014 Feb 21;9(2):e88604. doi: 10.1371/journal.pone.0088604. eCollection 2014.

5.

Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters.

Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K, Elistratova EI, Sherstnev VV, Morozova-Roche LA.

J Neuroimmunol. 2007 May;186(1-2):181-92. Epub 2007 May 2.

PMID:
17477976
6.

S100B and NSE serum levels in patients with Parkinson's disease.

Schaf DV, Tort AB, Fricke D, Schestatsky P, Portela LV, Souza DO, Rieder CR.

Parkinsonism Relat Disord. 2005 Jan;11(1):39-43.

PMID:
15619461
7.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
8.

Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammation.

Gruden MA, Yanamandra K, Kucheryanu VG, Bocharova OR, Sherstnev VV, Morozova-Roche LA, Sewell RD.

Neuroimmunomodulation. 2012;19(6):334-42. doi: 10.1159/000341400. Epub 2012 Sep 11.

9.

Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: biomarkers for nervous system injury.

Abou-Donia MB, Abou-Donia MM, ElMasry EM, Monro JA, Mulder MF.

J Toxicol Environ Health A. 2013;76(6):363-80. doi: 10.1080/15287394.2013.765369.

PMID:
23557235
10.

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Mirza B, Hadberg H, Thomsen P, Moos T.

Neuroscience. 2000;95(2):425-32.

PMID:
10658622
11.

Anti-melanin antibodies are increased in sera in Parkinson's disease.

Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM.

Exp Neurol. 2009 Jun;217(2):297-301. doi: 10.1016/j.expneurol.2009.03.002. Epub 2009 Mar 13.

PMID:
19289120
12.

Specific changes in levels of autoantibodies to glutamate and opiate receptors induced by morphine administration in rats.

Granstrem O, Adriani W, Shumilina M, Izykenova G, Dambinova S, Laviola G.

Neurosci Lett. 2006 Jul 31;403(1-2):1-5. Epub 2006 May 9.

PMID:
16687214
13.

Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome.

Fujii C, Tokuda T, Ishigami N, Mizuno T, Nakagawa M.

Neurosci Lett. 2011 Apr 20;494(1):86-8. doi: 10.1016/j.neulet.2011.02.063. Epub 2011 Mar 1.

PMID:
21371524
14.

Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats.

Higashino H, Niwa A, Satou T, Ohta Y, Hashimoto S, Tabuchi M, Ooshima K.

J Neural Transm (Vienna). 2009 Oct;116(10):1209-19. doi: 10.1007/s00702-009-0278-x. Epub 2009 Aug 6.

15.

Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders.

Poletaev AB, Morozov SG, Gnedenko BB, Zlunikin VM, Korzhenevskey DA.

Autoimmunity. 2000;32(1):33-8.

PMID:
10958173
16.

S100B in neuropathologic states: the CRP of the brain?

Sen J, Belli A.

J Neurosci Res. 2007 May 15;85(7):1373-80. Review.

PMID:
17348038
17.

Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

Scalzo P, Kümmer A, Cardoso F, Teixeira AL.

J Neuroimmunol. 2009 Nov 30;216(1-2):122-5. doi: 10.1016/j.jneuroim.2009.08.001. Epub 2009 Sep 3.

PMID:
19732964
18.

Lowered serum amyloid-β1-42 autoantibodies in individuals with lifetime depression.

Maetzler W, Langkamp M, Lerche S, Godau J, Brockmann K, Gaenslen A, Huber H, Wurster I, Niebler R, Eschweiler GW, Berg D.

J Alzheimers Dis. 2012;32(1):95-100.

PMID:
22766733
19.

Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.

DeMarshall CA, Han M, Nagele EP, Sarkar A, Acharya NK, Godsey G, Goldwaser EL, Kosciuk M, Thayasivam U, Belinka B, Nagele RG; Parkinson’s Study Group Investigators.

Immunol Lett. 2015 Nov;168(1):80-8. doi: 10.1016/j.imlet.2015.09.010. Epub 2015 Sep 16.

20.

The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.

Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RD, Gudasheva TA, Samokhin AN, Seredinin SB, Noppe W, Sherstnev VV, Morozova-Roche LA.

J Psychopharmacol. 2007 Aug;21(6):611-9. Epub 2006 Nov 8.

PMID:
17092975

Supplemental Content

Support Center